InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.19%
)
US TECH 100
19,107.20
(
-1.02%
)
Dow Jones
40,358.09
(
-0.16%
)
Brent Oil
80.69
(
-0.11%
)
Bitcoin
66,000.00
(
0.12%
)
Post# of 252655
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

gdollasign

Send PM Follow Ignore
Followers 6
Posts 973
Boards Moderated 0
Alias Born 06/08/2010

gdollasign

Re: DewDiligence post# 181134

Monday, 08/11/2014 6:26:14 PM

Monday, August 11, 2014 6:26:14 PM

Post# of 252655
Ref: www.clinicaltrials.gov/ct2/show/NCT02130557

Thanks to jaybe on SI:

http://www.siliconinvestor.com/readmsg.aspx?msgid=29665757

I would think that if the 30mg ponatinib study that began in 2012 by Dr.C is successful in alleviating the SAE's with continued BIC efficacy then the Bosulif study will turn out to be a waste of time imo. I am betting on Dr Cortes to figure it out as he had seemingly done a long time ago as I recall from previous data.

I am not in ARIA anymore but will be at some point if it flushes again.

G$
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up